查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067731

藥物篩檢市場規模、佔有率和趨勢分析報告：按產品、檢體、最終用途、地區和細分市場分類（2026-2033 年）

Drug Screening Market Size, Share & Trends Analysis Report By Product (Instruments, Rapid Testing Devices), By Sample (Urine Sample, Breath Sample, Oral Samples), By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

藥物篩檢市場概覽

全球藥物篩檢市場預計到 2025 年將達到 110.8 億美元，預計到 2033 年將從 2026 年的 118 億美元成長到 190.9 億美元，2026 年至 2033 年的複合年成長率為 7.12%。

到 2025 年，北美藥物篩檢產業將佔據最大的市場佔有率，達到 38.60%。

市場成長要素包括醫療保健和體育等領域對藥物檢測的需求不斷成長，而這又受到藥物濫用增加、更嚴格的監管、政府資助、技術進步以及有效檢測和控制藥物濫用的需要等因素的推動。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 產業分析工具

第4章：依產品進行業務分析

  • 藥物篩檢市場：基於產品的波動分析
  • 裝置
    • 設備市場市場估算與預測（2021-2033 年）
    • 免疫檢測
    • 層析法裝置
    • 呼氣酒精分析儀
  • 快速檢測裝置
    • 快速檢測設備市場估算與預測（2021-2033 年）
    • 尿液檢查裝置
    • 口腔液檢測裝置
  • 消耗品
    • 消費品市場估算與預測（2021-2033 年）
    • 檢測試劑盒
    • 檢體採集裝置
    • 校準器和控制器
    • 其他
  • 服務及其他
    • 服務業及其他市場估計與預測（2021-2033 年）

第5章：業務分析範例

  • 藥物篩檢市場：檢體波動分析
  • 尿液檢體
    • 呼吸檢體市場市場估算與預測（2021-2033 年）
  • 尿液檢體
    • 呼吸檢體市場市場估算與預測（2021-2033 年）
  • 口腔液檢體
    • 口腔液檢體市場估算與預測（2021-2033）
  • 頭髮檢體
    • 頭髮檢體市場估計與預測（2021-2033 年）
  • 其他檢體
    • 其他檢體市場的估計和預測（2021-2033 年）

第6章：依最終用途進行業務分析

  • 醫院
    • 醫院市場估計與預測（2021-2033）
  • 刑事司法和執法機關
    • 刑事司法與執法機關市場估算與預測（2021-2033）
  • 職場
    • 職場市場估算與預測（2021-2033 年）
  • 藥物治療中心
    • 藥物治療中心市場估算與預測（2021-2033 年）
  • 個人用戶
    • 個人用戶市場估算與預測（2021-2033 年）
  • 疼痛管理中心
    • 疼痛管理中心市場估計與預測（2021-2033）
  • 學校和學院
    • 學校和大學市場估算和預測（2021-2033 年）
  • 其他
    • 其他市場的估計和預測（2021-2033 年）

第7章 區域業務分析

  • 藥物篩檢市場佔有率：按地區分類，2025 年和 2033 年
  • 北美洲
    • SWOT分析
    • 2021-2033年北美藥物篩檢市場
    • 美國
    • 墨西哥
    • 加拿大
  • 歐洲
    • SWOT分析
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • SWOT分析
    • 巴西
    • 阿根廷
  • 中東和非洲
    • SWOT分析
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 科威特

第8章 競爭情勢

  • 公司分類
  • 策略規劃
  • 2022年企業市場占有率分析
  • 公司簡介列表
    • Abbott
    • Quest Diagnostics Incorporated
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc
    • Siemens Healthcare AG
    • Laboratory Corporation of America Holdings
    • Alfa Scientific Designs, Inc.
    • OraSure Technologies, Inc
    • Omega Laboratories, Inc.
    • Dragerwerk AG & Co. KGaA
    • Bio-Rad Laboratories, Inc.
Product Code: GVR-4-68040-303-9

Drug Screening Market Summary

The global drug screening market size was estimated at USD 11.08 billion in 2025 and is projected to grow from USD 11.80 billion in 2026 to USD 19.09 billion by 2033, at a CAGR of 7.12% from 2026 to 2033. The North America drug screening industry accounted for the largest revenue share of 38.60% in 2025.

The growth of the market is attributed to the rising substance abuse, stringent regulations, government funding, technological advancements, and increasing demand for substance testing across sectors like healthcare and sports, driven by the need for effective substance abuse detection and management.

Global Drug Screening Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global drug screening market report based on product, sample, end use, and region.

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Instruments
    • Immunoassays Analyzers
    • Chromatography Instruments
    • Breath Analyzer
    • Fuel Cell Breath Analyzer
    • Semi-Conductor Breath Analyzer
    • Others Breath Analyzer
  • Rapid Testing Devices
    • Urine Testing Devices
    • Drug Testing Cups
    • Dip Cards
    • Drug Testing Cassettes
    • Oral Fluid Testing Devices
  • Consumables
    • Assay Kits
    • Sample Collection Devices
    • Calibrators & Controls
    • Other Consumables
  • Services and Others
  • Sample Outlook (Revenue, USD Billion, 2021 - 2033)
  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals
  • Criminal Justice & Law Enforcement Agencies
  • Workplaces
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools & Colleges
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Sample Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
    • 1.3.1. Objectives
    • 1.3.2. Objective - 1
    • 1.3.3. Objective - 2
    • 1.3.4. Objective - 3
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product & Sample type Snapshot
  • 2.3. End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Increasing drug and alcohol consumption
    • 3.2.3. Growing demand for drug screening measures
    • 3.2.4. Rise in government funding
    • 3.2.5. Market Restraint Analysis
      • 3.2.5.1. Rising false positive and negative results in drug screeni9ng limits screening process
      • 3.2.5.2. Rise in privacy concerns limiting the expansion of drug screening practices
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

  • 4.1. Drug Screening Market: Technology Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments market estimates and forecasts 2021 to 2033 (USD Billion)
    • 4.2.2. Immunoassays Analyzers
      • 4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
    • 4.2.3. Chromatography Instruments
      • 4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
    • 4.2.4. Breath Analyzer
      • 4.2.4.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
      • 4.2.4.2. Fuel Cell Breath Analyzer
        • 4.2.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
      • 4.2.4.3. Semi-Conductor Breath Analyzer
        • 4.2.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
      • 4.2.4.4. Others Breath Analyzer
        • 4.2.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.3. Rapid Testing Devices
    • 4.3.1. Rapid testing devices market estimates and forecasts 2021 to 2033 (USD Billion)
    • 4.3.2. Urine Testing Devices
      • 4.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
      • 4.3.2.2. Drug Testing Cups
        • 4.3.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
      • 4.3.2.3. Dip Cards
        • 4.3.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
      • 4.3.2.4. Drug Testing Cassettes
        • 4.3.2.4.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
    • 4.3.3. Oral Fluid Testing Devices
      • 4.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts 2021 to 2033 (USD Billion)
    • 4.4.2. Assay Kits
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
    • 4.4.3. Sample Collection Devices
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
    • 4.4.4. Calibrators & Controls
      • 4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
    • 4.4.5. Other Consumables
      • 4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.5. Services and Others
    • 4.5.1. Services and others market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 5. Sample Business Analysis

  • 5.1. Drug Screening Market: Sample Movement Analysis
  • 5.2. Urine Samples
    • 5.2.1. Urine samples market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.3. Breath Samples
    • 5.3.1. Breath samples market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.4. Oral Fluid Samples
    • 5.4.1. Oral fluid samples market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.5. Hair Samples
    • 5.5.1. Hair samples market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.6. Other Samples
    • 5.6.1. Other samples market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 6. End Use Business Analysis

  • 6.1. Hospitals
    • 6.1.1. Hospitals market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.2. Criminal Justice & Law Enforcement Agencies
    • 6.2.1. Clinical laboratories market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.3. Workplaces
    • 6.3.1. Workplaces market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.4. Drug Treatment Centers
    • 6.4.1. Drug treatment centers market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.5. Individual Users
    • 6.5.1. Individual users market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.6. Pain Management Centers
    • 6.6.1. Pain management centers market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.7. Schools & Colleges
    • 6.7.1. Schools & Colleges market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.8. Others
    • 6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 7. Regional Business Analysis

  • 7.1. Drug Screening Market Share By Region, 2025 & 2033
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Drug Screening Market, 2021-2033 (USD Billion)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. U.S. Drug Screening Market, 2021-2033 (USD Billion)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Mexico Drug Screening Market, 2021-2033 (USD Billion)
    • 7.2.5. Canada
      • 7.2.5.1. Key Country Dynamics
      • 7.2.5.2. Target Disease Prevalence
      • 7.2.5.3. Competitive Scenario
      • 7.2.5.4. Regulatory Framework
      • 7.2.5.5. Canada Drug Screening Market, 2021-2033 (USD Billion)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
      • 7.3.1.1. Europe Drug Screening Market, 2021-2033 (USD Billion)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. UK Drug Screening Market, 2021-2033 (USD Billion)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Germany Drug Screening Market, 2021-2033 (USD Billion)
    • 7.3.4. Spain
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Spain Drug Screening Market, 2021-2033 (USD Billion)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. France Drug Screening Market, 2021-2033 (USD Billion)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Italy Drug Screening Market, 2021-2033 (USD Billion)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Denmark Drug Screening Market, 2021-2033 (USD Billion)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Sweden Drug Screening Market, 2021-2033 (USD Billion)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Norway Drug Screening Market, 2021-2033 (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
      • 7.4.1.1. Asia Pacific Drug Screening Market, 2021-2033 (USD Billion)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Japan Drug Screening Market, 2021-2033 (USD Billion)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. China Drug Screening Market, 2021-2033 (USD Billion)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. India Drug Screening Market, 2021-2033 (USD Billion)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. South Korea Drug Screening Market, 2021-2033 (USD Billion)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Australia Drug Screening Market, 2021-2033 (USD Billion)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Thailand Drug Screening Market, 2021-2033 (USD Billion)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
      • 7.5.1.1. Latin America Drug Screening Market, 2021-2033 (USD Billion)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Brazil Drug Screening Market, 2021-2033 (USD Billion)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Argentina Drug Screening Market, 2021-2033 (USD Billion)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
      • 7.6.1.1. MEA Drug Screening Market, 2021-2033 (USD Billion)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. South Africa Drug Screening Market, 2021-2033 (USD Billion)
    • 7.6.3. UAE
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. UAE Drug Screening Market, 2021-2033 (USD Billion)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Saudi Arabia Drug Screening Market, 2021-2033 (USD Billion)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Kuwait Drug Screening Market, 2021-2033 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Abbott
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Technology Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Quest Diagnostics Incorporated
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Technology Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. F. Hoffmann-La Roche Ltd
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Technology Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Thermo Fisher Scientific Inc
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Technology Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Siemens Healthcare AG
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Technology Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Laboratory Corporation of America Holdings
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Technology Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Alfa Scientific Designs, Inc.,
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Technology Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. OraSure Technologies, Inc
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Technology Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Omega Laboratories, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Technology Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Dragerwerk AG & Co. KGaA
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Technology Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Bio-Rad Laboratories, Inc.
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.11.3. Technology Benchmarking
      • 8.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global drug screening market, by region, 2021 - 2033 (USD Billion)
  • Table 3 Global drug screening market, by product, 2021 - 2033 (USD Billion)
  • Table 4 Global drug screening market, by sample, 2021 - 2033 (USD Billion)
  • Table 5 Global drug screening market, by end use, 2021 - 2033 (USD Billion)
  • Table 6 North America drug screening market, by region, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 7 North America drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 8 North America drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 9 North America drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 10 U.S. drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 11 U.S. drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 12 U.S. drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 13 Canada drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 14 Canada drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 15 Canada drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 16 Mexico drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 17 Mexico drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 18 Mexico drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 19 Europe drug screening market, by region, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 20 Europe drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 21 Europe drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 22 Europe drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 23 Germany drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 24 Germany drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 25 Germany drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 26 UK drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 27 UK drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 28 UK drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 29 France drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 30 France drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 31 France drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 32 Italy drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 33 Italy drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 34 Italy drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 35 Spain drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 36 Spain drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 37 Spain drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 38 Denmark drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 39 Denmark drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 40 Denmark drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 41 Sweden drug screening market, by product, (USD Billion2021 - 2033 (USD Billion)
  • Table 42 Sweden drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 43 Sweden drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 44 Norway drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 45 Norway drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 46 Norway drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 47 Asia Pacific drug screening market, by region, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 48 Asia Pacific drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 49 Asia Pacific drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 50 Asia Pacific drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 51 China drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 52 China drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 53 China drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 54 Japan drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 55 Japan drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 56 Japan drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 57 India drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 58 India drug screening market, by sample, (USD Billion) 2021 - 2033 USD Billion)
  • Table 59 India drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 60 South Korea drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 61 South Korea drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 62 South Korea drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 63 Australia drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 64 Australia drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 65 Australia drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 66 Thailand drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 67 Thailand drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 68 Thailand drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 69 Latin America drug screening market, by region, (USD Billion) 2021 - 2033 USD Billion)
  • Table 70 Latin America drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 71 Latin America drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 72 Latin America drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 73 Brazil drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 74 Brazil drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 75 Brazil drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 76 Argentina drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 77 Argentina drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 78 Argentina drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 79 MEA drug screening market, by region, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 80 MEA drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 81 MEA drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 82 MEA drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 83 South Africa drug screening market, by product, (USD Billion) 2021 - 2033 USD Billion)
  • Table 84 South Africa drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 85 South Africa drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 86 Saudi Arabia drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 87 Saudi Arabia drug screening market, by sample, (USD Billion) 2021 - 2033(USD Billion)
  • Table 88 Saudi Arabia drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 89 UAE drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 90 UAE drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 91 UAE drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 92 Kuwait drug screening market, by product, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 93 Kuwait drug screening market, by sample, (USD Billion) 2021 - 2033 (USD Billion)
  • Table 94 Kuwait drug screening market, by end use, (USD Billion) 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Drug Screening market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Technology and end use snapshot
  • Fig. 11 Application and modality Segment snapshot
  • Fig. 12 Competitive landscape snapshot
  • Fig. 14 Market trends & outlook
  • Fig. 19 Porter's five force analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Drug screening market: Product movement analysis
  • Fig. 20 Drug screening market: Product outlook and key takeaways
  • Fig. 21 Instruments market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 22 Rapid testing devices estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 23 Consumables estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 24 Services and others market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 25 Drug screening market: Sample movement analysis
  • Fig. 26 Drug screening market: Sample outlook and key takeaways
  • Fig. 27 Urine samples market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 28 Breath samples estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 29 Oral fluid samples market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 30 Hair samples estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 31 Other samples estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 32 Drug screening market: End Use movement analysis
  • Fig. 33 Drug screening market: End Use outlook and key takeaways
  • Fig. 34 Hospitals market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 35 Criminal justice and law enforcement agencies estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 36 Workplaces market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 37 Drug treatment centers market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 38 Individual users market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 39 Pain management centers market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 40 Schools and colleges market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 41 Others market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 42 Global drug screening market: Regional movement analysis
  • Fig. 43 Global drug screening market: Regional outlook and key takeaways
  • Fig. 44 Global drug screening market share and leading players
  • Fig. 45 North America, by country
  • Fig. 46 North America market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 47 U.S. key country dynamics
  • Fig. 48 U.S. market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 49 Canada key country dynamics
  • Fig. 50 Canada market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 51 Mexico key country dynamics
  • Fig. 52 Mexico market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 53 Europe market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 54 UK key country dynamics
  • Fig. 55 UK market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 56 Germany key country dynamics
  • Fig. 57 Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 58 France key country dynamics
  • Fig. 59 France market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 60 Italy key country dynamics
  • Fig. 61 Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 62 Spain key country dynamics
  • Fig. 63 Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 64 Denmark key country dynamics
  • Fig. 65 Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 66 Sweden key country dynamics
  • Fig. 67 Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 68 Norway key country dynamics
  • Fig. 69 Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 70 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 71 China key country dynamics
  • Fig. 72 China market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 73 Japan key country dynamics
  • Fig. 74 Japan market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 75 India key country dynamics
  • Fig. 76 India market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 77 Thailand key country dynamics
  • Fig. 78 Thailand market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 79 South Korea key country dynamics
  • Fig. 80 South Korea market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 81 Australia key country dynamics
  • Fig. 82 Australia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 83 Latin America market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 84 Brazil key country dynamics
  • Fig. 85 Brazil market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 86 Argentina key country dynamics
  • Fig. 87 Argentina market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 88 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 89 South Africa key country dynamics
  • Fig. 90 South Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 91 Saudi Arabia key country dynamics
  • Fig. 92 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 93 UAE key country dynamics
  • Fig. 94 UAE market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 95 Kuwait key country dynamics
  • Fig. 96 Kuwait market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 97 Market share of key market players- Drug screening market
  • Fig. 142 Key company categorization
  • Fig. 143 Company market share analysis, 2025
  • Fig. 144 Strategic framework